產品詳情
查看大圖

  • 產品名稱：CRL-1803 TT 人甲狀腺導管癌細胞

  • 產品型號：CRL-1803
  • 產品廠商：其它品牌
  • 產品文檔：
你添加了1件商品 查看購物車
簡單介紹：
簡單介紹 CRL-1803 TT 人甲狀腺導管癌細胞， ATCC 細胞|細胞係|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞；細胞庫管理規範，提供的細胞株背景清楚，提供參考文獻和**培養條件！
詳情介紹：

CRL-1803 TT 人甲狀腺導管癌細胞 的詳細介紹
CRL-1803 TT 人甲狀腺導管癌細胞
ATCC® Number: CRL-1803™     Price:  
Designations: TT
Depositors:  SS Leong
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: adherent
Organism: Homo sapiens (human)
Morphology: epithelial
Source: Organ: thyroid 
Tissue: medulla 
Disease: carcinoma
Cellular Products: calcitonin; carcinoembryonic antigen (CEA) [21867]
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
 
Tumorigenic: Yes
DNA Profile (STR): Amelogenin: X 
CSF1PO: 10,13 
D13S317: 11 
D16S539: 12,13 
D5S818: 12,13 
D7S820: 10,12 
THO1: 6,9 
TPOX: 8,11 
vWA: 16,18
Cytogenetic Analysis: aneuploid with several markers; modal number = 40; range = 32 to 86 [21867]
Age: 77 years
Gender: female
Ethnicity: Caucasian
Comments: The TT cell line was established by S.S. Leong, et al. from a specimen obtained by needle biopsy from a 77 year old female with thyroid medullary carcinoma. [21867] 
TT cells continuously produce high levels of calcitonin and CEA. [21867] 
Immunoreactive calcitonin was found to be produced in cell culture at levels of 3900 pg/million cells and 7700 pg/million cells 24 and 72 hours respectively after a medium change. [21867] 
CEA was found to accumulate to greater than 27 ng/million cells over a 72 hours period. [21867] 
Chromosomal analysis of the cell line and tumors induced in nude mice reveal an aneuploid human karyotype with several marker chromosomes. [21867] 
The initial characterization studies of the TT cell line were conducted using early passage TT cells cultivated in RPMI 1640 medium supplemented with 15% fetal bovine serum and 1 mM L-glutamine. 
It is not known if the neuropeptides reported to be produced by this cell line when it was grown in RPMI 1640 medium are also produced by the cells when they are cultured in Ham's F12K medium.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated F-12K Medium, Catalog No. 30-2004. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:4 is recommended 
Medium Renewal: Twice per week 
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. 
Add fresh culture medium, aspirate and dispense into new culture flasks.
Preservation: Culture medium, 95%; DMSO, 5%
Doubling Time: 83 hrs
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2004
recommended serum:ATCC 30-2020
References: 21867: . Advances in thyroid neoplasia, 1981. Rome: Field Educational Italia; 1981.
32264: Behr TM, et al. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Cancer Res. 57: 5309-5319, 1997. PubMed: 9393755

滬公網安備 31010902002433號